1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US20040024023A1
公开(公告)日:2004-02-05
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
1
本发明提供了一种公式I的化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。